Lupin acquires anti-diabetes trademarks from Boehringer Ingelheim to strengthen portfolio EP News Bureau Dec 16, 2024 Lupin expands its diabetes portfolio with the acquisition of GIBTULIO, GIBTULIO MET, and AJADUO trademarks
Cipla strengthens its anti-diabetes portfolio through partnerships with MNCs: GlobalData EP News Bureau Apr 27, 2023 Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01…
